All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2004-002496-17 | A Six-Month Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment... | 2008-09-16 | due-trials |
| Reported results | 2004-002502-29 | A Six-Month Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment... | 2008-09-01 | due-trials |
| Not reported | 2004-003675-36 | A randomised, open label study to compare the efficacy and safety of a dry powder formulation of inhaled Colistimethate Sodium and nebulised TNSFI (Tobramycin nebuliser solution for inhalation, TOBI®)... | 2007-08-14 | due-trials |
| Reported results | 2004-004996-12 | A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Appli... | 2012-06-01 | due-trials |
| Reported results | 2004-004997-10 | A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Appli... | 2012-05-29 | due-trials |
| Reported results | 2005-001936-59 | A multicenter, double-blind, randomized, placebo-controlled, parallel-group, dose-response study of the safety and efficacy of a single treatment of BOTOX® (botulinum toxin type A) purified neurotoxin... | 2008-06-26 | due-trials |
| Reported results | 2005-004281-17 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study to Evaluate the Safety and Efficacy of a Single Treatment of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Comple... | 2010-05-27 | due-trials |
| Reported results | 2005-004637-17 | A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-W... | 2008-08-11 | due-trials |
| Reported results | 2005-004834-42 | A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Safety Study of Pulmonary Function in Patients with Reduced Lung Function Treated with BOTOX® (Botulinum Toxin Type A) Purified Neuroto... | 2009-08-28 | due-trials |
| Reported results Terminated | 2005-006169-15 | A Double-Blind, Randomised, Cross-over, Safety and Efficacy Pilot Study Comparing Two Botulinum Toxin Type-A Products in the Treatment of Moderate to Severe Cervical Dystonia. | 2007-09-09 | due-trials |
| Reported results | 2005-006170-10 | A Double-Blind, Randomised, Parallel group, Safety and Efficacy Pilot Study Comparing Two Botulinum Toxin Type-A Products in the Treatment of Blepharospasm | 2008-01-29 | due-trials |
| Reported results | 2006-000736-26 | An 8-Week, Multicenter, Masked, Randomized Trial with an 18-Week Masked Extension to Assess the Safety and Efficacy of 700 g and 350 g Dexamethasone Posterior Segment Drug Delivery System DEX PS ... | 2009-04-28 | due-trials |
| Reported results | 2006-000737-36 | A 6-Week, Multicenter, Masked, Randomized Trial (with a 20-Week Masked Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DD... | 2007-03-15 | due-trials |
| Reported results | 2006-002143-83 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment with Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neur... | 2010-05-04 | due-trials |
| Reported results | 2006-005283-47 | A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin plus Aztreonam in Adult Subjects with Complicated Skin and Ski... | 2008-08-31 | due-trials |
| Completed, but no date, and reported results | 2006-005332-25 | A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin plus Aztreonam in Adult Subjects with Complicated Skin and Ski... | bad-data | |
| Reported results | 2006-006100-11 | A multicenter, multiple dose, double-blind, randomized, placebo-controlled, parallel group study of the safety and efficacy of AGN 203818 in female patients with fibromyalgia syndrome. | 2009-10-27 | due-trials |
| Reported results | 2006-006299-39 | A Placebo-Controlled, Randomized, Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Neurogenic Detrusor Overactivity and Neurological Respirator... | 2012-12-05 | due-trials |
| Reported results | 2006-006449-14 | A study to compare the efficacy and safety of two different types of Botulinum Toxin Type A (BOTOX or Dysport) in the Treatment of Moderate to Severe Cervical Dystonia | 2009-09-23 | due-trials |
| Reported results | 2007-000192-42 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment with Two Dose Levels of BOTOX (Botulinum Toxin Type A) Purified Neuro... | 2010-04-15 | due-trials |
| Reported results | 2007-000598-41 | "A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline versus Ceftriaxone, with Adjunctive Clarithromycin, in the Treatment of Adult Su... | 2009-04-03 | due-trials |
| Reported results | 2007-000599-18 | A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline versus Ceftriaxone in the Treatment of Adult Subjects with Community-Acquired Pne... | 2009-04-03 | due-trials |
| Reported results | 2007-000735-26 | A Multicentre, Double-Blind, Prospective, Randomised, European and Canadian Study to Evaluate Patient Outcomes and Costs of Managing Adults with Spasticity and Associated Focal Spasticity. | 2010-07-26 | due-trials |
| Reported results | 2007-003407-12 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Explore the Dose Dependent Response to Three Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Com... | 2010-07-16 | due-trials |
| Reported results Terminated | 2007-003787-21 | A Pilot, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study with a 4-Week Treatment Period Followed by a 4-week Observation Period and an Optional 4 Month Observation Period of the Safet... | 2008-06-20 | due-trials |
| Reported results | 2007-004416-31 | A 6 MONTH, SINGLE-MASKED, MULTICENTER, RANDOMIZED, CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF 700 µg DEXAMETHASONE POSTERIOR SEGMENT DRUG DELIVERY SYSTEM APPLICATOR SYSTEM AS ADJUNTIVE THER... | 2009-03-08 | due-trials |
| Reported results | 2007-004530-16 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Single Treatment Cycle, Parallel Evaluation of the Safety, Efficacy and Immunogenicity of Two Formulations of BOTOX® (Botulinum Toxin Type ... | 2009-12-28 | due-trials |
| Reported results | 2008-001487-37 | A Multicenter, Masked, Randomized, Sham-controlled, Paired-eye Comparison, 12-Month (Plus 12-Month Extension) Study to Evaluate the Safety and Effects on Retinal Structure and Visual Function of Brimo... | 2011-04-08 | due-trials |
| Reported results | 2009-009216-53 | "Estudio multicéntrico de seguimiento a largo plazo de la seguridad y eficacia de dos niveles de dosis del complejo de neurotoxina purificada BOTOX® (toxina botulínica tipo A) en pacientes con inconti... | 2013-09-04 | due-trials |
| Reported results | 2009-012304-55 | A One Year, Multicenter, Double-Masked, Randomized, Parallel-Group Study Assessing the Safety and Efficacy of Once Daily Application of Bimatoprost 0.03% Solution Compared to Vehicle to Treat Hypotric... | 2011-05-10 | due-trials |
| Reported results | 2009-012446-23 | A MULTICENTER, RANDOMIZED, DOUBLE MASKED, PARALLEL GROUP STUDY EVALUATING THE EFFICACY AND SAFETY OF CYCLOSPORINE OPHTHALMIC SOLUTION 0,010% COMPARED WITH ITS VEHICLE ADMINISTRATED QID FOR 3 MONTHS F... | 2011-07-29 | due-trials |
| Reported results | 2009-012597-13 | A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Dutogliptin in Patients with Type 2 Diabetes Mellitus on Background Treatment with G... | 2010-07-23 | due-trials |
| Reported results Terminated | 2009-012598-37 | A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF DUTOGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ON BACKGROUND TREATMENT WITH P... | 2010-08-12 | due-trials |
| Reported results | 2009-012799-28 | A 3-Month, Multicenter, Investigator masked, Pilot Study to Evaluate the Efficacy and Safety of Bimatoprost/Timolol Fixed Combination vs Latanoprost in treatment Naïve Patients with Open Angle Glaucom... | 2012-02-14 | due-trials |
| Reported results | 2009-013088-20 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex Follow... | 2011-08-17 | due-trials |
| Reported results | 2009-013089-26 | A Multicenter, Long-term Follow-up Study of the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Idiopathic Overactive Bladder with Urinary Incontine... | 2014-08-05 | due-trials |
| Reported results | 2009-015586-31 | A Multicenter, Masked, Randomized, Sham-Controlled, Parallel-Group, 3 Month Study with a 9-Month Safety Extension to Evaluate the Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Del... | 2011-07-18 | due-trials |
| Reported results | 2009-016041-25 | A Long-Term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder | 2012-02-27 | due-trials |
| Reported results Terminated | 2009-017266-23 | A Phase III, Multicenter, Randomized, Double-blind, Placebo-Controlled, Safety Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus Treated With Dutogliptin | 2010-06-03 | due-trials |
| Reported results | 2009-017524-36 | A Phase III, Multicenter, Double-blind, Active-Controlled, 52-Week Extension Study to Evaluate the Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Tre... | 2010-06-23 | due-trials |
| Completed, but no date, and reported results Terminated | 2010-018405-12 | Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients with Schizophrenia | bad-data | |
| Reported results | 2010-018671-20 | A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phase 3... | 2015-04-30 | due-trials |
| Reported results | 2010-019079-32 | A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System | 2014-02-05 | due-trials |
| Reported results | 2010-020172-30 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Intraprostatic Administration of BOTOX® 200 U (Botulinum Toxin Type A) Purified Neuroto... | 2012-06-14 | due-trials |
| Reported results | 2010-020827-28 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Single Treatment Cycle Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects with Lateral Cantha... | 2011-07-16 | due-trials |
| Reported results | 2010-020828-21 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects with Fa... | 2011-09-13 | due-trials |
| Reported results | 2010-020977-18 | A Multicenter, Double-blind, Randomized, Placebo-controlled, Repeat Treatment (two cycle) Study of the Safety and Efficacy of AGN-214868 in Patients with Postherpetic Neuralgia | 2012-01-19 | due-trials |
| Reported results | 2010-021271-83 | A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Extension Study to Evaluate the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjec... | 2012-02-08 | due-trials |
| Reported results | 2010-021401-20 | A Multicenter, Randomised, Double-Blind Study to Evaluate the Efficacy of VISTABEL® (20 units) in the Treatment of Glabellar Lines, When Compared to BOCOUTURE® (30 units) | 2011-04-04 | due-trials |
| Reported results | 2010-021507-24 | A Multicenter, Double-masked, Randomized, Parallel Study of the Safety and Efficacy of Bimatoprost 0.03%/Timolol 0.5% Preservative freeOphthalmic Solution Compared with GANFORT® (bimatoprost 0.03%/tim... | 2012-02-20 | due-trials |
| Reported results | 2010-021718-41 | A Pilot, Multicenter, Double-blind, Placebo-controlled, Dose-escalation Study of the Safety and Efficacy of AGN-214868 in Patients with Idiopathic Overactive Bladder and Urinary Incontinence | 2013-05-03 | due-trials |
| Reported results | 2010-022487-12 | A Phase 2, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Coadministered Ceftaroline fosamil and NXL104 Versus Intravenous Doripenem in Adu... | 2012-08-03 | due-trials |
| Reported results | 2010-023900-29 | A 12-Month, Multicentre, Randomised, Parallel Group Study to Compare the Efficacy and Safety of Ozurdex Versus Lucentis in Patients with Branch Retinal Vein Occlusion Studio multicentrico, randomiz... | 2014-11-04 | due-trials |
| Reported results | 2010-023917-68 | A 2-year, multicenter, double-masked, randomized, parallel study of the safety of LUMIGAN 0.1 mg/mL compared with LUMIGAN 0.3 mg/mL in patients with glaucoma or ocular hypertension | 2016-12-06 | due-trials |
| Reported results | 2010-024042-30 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO COMPARE THE EFFICACY AND SAFETY OF DALBAVANCIN TO A COMPARATOR REGIMEN (VANCOMYCIN AND LINEZOLID) FOR THE TREATMENT OF ACUTE BACTERIAL SKIN A... | 2012-11-07 | due-trials |
| Exempt | 2011-000192-13 | A 7-day open-label pharmacokinetic study to investigate the systemic absorption of colistimethate sodium after inhalation of dry powder colistimethate sodium for inhalation (Colobreathe® 125mg) in adu... | 2012-04-23 | not-yet-due |
| Reported results | 2011-000379-15 | A Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety and Efficacy of Bimatoprost Solution 0.03%, 0.1%, and 0.3% Compared with Vehicle in Men with Androgenic Alopecia wi... | 2012-09-10 | due-trials |
| Reported results | 2011-000380-27 | A Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety and Efficacy of Bimatoprost Solution 0.03%, 0.1%, and 0.3% Compared with Vehicle in Women with Female Pattern Hair ... | 2012-09-10 | due-trials |
| Reported results | 2011-001245-32 | A Phase 3, Randomized, Double-Blind Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) | 2012-04-18 | due-trials |
| Reported results | 2011-002048-29 | A randomized, double-blind, placebo-controlled, parallel-group study of cariprazine (RGH-188) in the prevention of relapse in patients with schizophrenia | 2014-09-03 | due-trials |
| Reported results | 2011-002130-40 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO COMPARE THE EFFICACY AND SAFETY OF DALBAVANCIN TO A COMPARATOR REGIMEN (VANCOMYCIN AND LINEZOLID) FOR THE TREATMENT OF ACUTE BACTERIAL SKIN A... | 2013-01-11 | due-trials |
| Trial is outside EEC, and reported results | 2011-002198-44 | Pharmacokinetics of a Single Dose of Ceftaroline fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Infection | bad-data | |
| Reported results | 2011-002334-39 | A Double-blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression | 2014-01-10 | due-trials |
| Reported results | 2011-002526-43 | Single and Repeat Dose Study of the Safety and Efficacy of AGN-150998 in Patients with Exudative Age-related Macular Degeneration | 2014-04-09 | due-trials |
| Completed, but no date, and reported results | 2011-002768-25 | A Single Center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Osteoarth... | bad-data | |
| Listed as ongoing, but also has a completion date and reported results | 2011-003278-10 | A Multicenter, Double-masked, Randomized, Active-controlled, Parallel Study of the Safety and Efficacy of Once-daily Bimatoprost Preservative-free Ophthalmic Solution Compared to Twice-daily Timolol O... | 2014-09-30 | bad-data |
| Reported results | 2011-003606-24 | A 52-week, Double-Blind, Randomized, Placebo Controlled Parallel Group Study to Evaluate the Effect of Roflumilast 500 μg on Exacerbation Rate in Subjects with Chronic Obstructive Pulmonary Disease (... | 2015-11-24 | due-trials |
| Trial is partly outside EEC, and reported results | 2011-003812-22 | A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Ceftaroline Versus Comparator in Pediatric Subjects With Ac... | 2014-05-13 | bad-data |
| Reported results Terminated | 2011-004376-11 | A Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once-Daily Oral Doses of 75 mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizat... | 2013-06-14 | due-trials |
| Reported results | 2011-004980-63 | BOTOX® Treatment in Adult Patients with Post-Stroke Lower Limb Spasticity | 2015-07-01 | due-trials |
| Exempt, with results | 2011-005091-42 | An Open Label (Stage 1) and Randomized (Stage 2), 24-Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension | 2016-07-27 | not-yet-due |
| Reported results | 2011-005179-18 | A Double-blind, Placebo-controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy In Major Depressive Disorder. | 2013-12-11 | due-trials |
| Reported results | 2011-005631-20 | A Multicenter, Open-label, Randomized Study Comparing the Efficacy and Safety of 700 mcg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) to Ranibizumab in Patients With Diabetic Macu... | 2014-02-13 | due-trials |
| Reported results | 2012-000042-35 | BOTOX® Treatment in Pediatric Lower Limb Spasticity: Double-blind Study | 2018-06-28 | due-trials |
| Reported results | 2012-000043-27 | BOTOX® Treatment in Pediatric Upper Limb Spasticity: Open-label Study | 2018-09-03 | due-trials |
| Reported results | 2012-000062-38 | BOTOX® Treatment in Pediatric Upper Limb Spasticity: Double-blind Study | 2017-07-06 | due-trials |
| Reported results | 2012-000084-24 | BOTOX® Treatment in Pediatric Lower Limb Spasticity: Open-label Study | 2018-08-25 | due-trials |
| Reported results | 2012-000957-30 | BOTOX® for the Treatment of Urinary Incontinence due to Neurogenic Detrusor Overactivity in Patients with Multiple Sclerosis | 2015-03-27 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2012-001568-31 | A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of the Safety and Efficacy of Memantine in Pediatric Patients with Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not ... | 2013-09-11 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2012-001616-33 | An Open-Label Study Of The Safety And Tolerability Of Memantine In Pediatric Patients With Autism, Asperger’s Disorder, Or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) | 2013-07-09 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2012-001630-33 | An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients with Autism, Asperger’s Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) | 2014-01-31 | bad-data |
| Reported results | 2012-001950-25 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study with Vilazodone in Patients with Major Depressive Disorder | 2014-10-11 | due-trials |
| Reported results | 2012-002182-35 | A Multicenter, Multinational, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ceftaroline fosamil Versus Ceftriaxone Plus Vancomycin in Adult Subjects with Community-acquired Bac... | 2013-12-03 | due-trials |
| Trial is partly outside EEC, and reported results | 2012-002203-18 | A Multicenter, Randomized, Observer-Blinded, Active Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone in Pediatric Subjects With Co... | 2014-04-14 | bad-data |
| Reported results | 2012-002238-35 | A Multicenter, Double-masked, Randomized Study to Compare the Safety and Efficacy of an Investigational Eye Drop Formulation with OPTIVE™ Unit-Dose for 3 Months in Subjects with Dry Eye Disease St... | 2014-05-23 | due-trials |
| Reported results Terminated | 2012-002240-24 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Safety and Efficacy of a Single Treatment of AGN-214868 in Patients With Postherpetic Neuralgia | 2015-09-30 | due-trials |
| Reported results | 2012-003007-35 | Bimatoprost in the Treatment of Eyelash Hypotrichosis | 2014-04-01 | due-trials |
| Reported results | 2012-003255-11 | A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary Incontinence | 2015-03-18 | due-trials |
| Reported results | 2012-004877-26 | BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age | 2018-10-11 | due-trials |
| Reported results | 2012-004898-30 | Long-term Extension Study of BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age | 2019-10-03 | due-trials |
| Reported results | 2013-001650-94 | An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation | 2017-08-15 | due-trials |
| Reported results Terminated | 2013-002327-42 | Long-term Study of BOTOX® Treatment in Adult Patients with Upper Limb Spasticity | 2014-07-02 | due-trials |
| Reported results Terminated | 2013-002346-37 | BOTOX® Treatment in Adult Patients with Upper Limb Spasticity | 2015-08-11 | due-trials |
| Reported results | 2013-003227-11 | PHASE 1, OPEN LABEL, SINGLE DOSE STUDY TO INVESTIGATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF DALBAVANCIN IN HOSPITALIZED CHILDREN AGED 3 MONTHS TO 11 YEARS RECEIVING STANDARD INTRAVENOUS ANT... | 2015-04-16 | due-trials |
| Reported results | 2013-003320-36 | Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON Study) | 2018-03-30 | due-trials |
| Reported results | 2014-000419-15 | A Phase 3b, Double-Blind, Multicenter, Randomized Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and... | 2015-03-11 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2014-000464-17 | BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age | 2022-02-10 | bad-data |
| Reported results | 2014-001076-58 | BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis | 2016-03-07 | due-trials |
| Reported results | 2014-001815-38 | Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal ... | 2016-04-20 | due-trials |
| Reported results | 2014-001860-36 | Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Forehead and Glabellar Facial Rhytides | 2016-04-26 | due-trials |
| Completed, but no date, and reported results Terminated | 2014-002683-32 | A Phase 3, double-blinded, randomized, comparator trial of the safety and efficacy of a single dose of dalbavancin to twice daily linezolid for the treatment of community acquired bacterial pneumonia | bad-data | |
| Reported results | 2014-003037-26 | The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension | 2019-07-19 | due-trials |
| Reported results | 2014-003164-21 | Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects with Liver Fibrosis | 2017-07-20 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2014-003186-24 | The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension | 2020-07-22 | bad-data |
| Ongoing | 2014-004130-25 | A phase 3, Multicenter, Double-Blind, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin versus Active Comparator in Pediatric Subjects with Acute Hematogenous Osteomyel... | not-yet-due | |
| Reported results | 2014-004579-22 | Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration | 2019-04-16 | due-trials |
| Reported results | 2014-004580-20 | Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-related Macular Degeneration | 2019-04-03 | due-trials |
| Other | 2014-005279-10 | A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Lateral Canthal Lines | not-yet-due | |
| Reported results | 2014-005281-30 | A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin versus Active Comparator in Pediatric Subjects with Acute Bacterial Skin and Skin ... | 2022-03-30 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2014-005301-21 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines With or Wit... | 2021-01-22 | bad-data |
| Reported results | 2014-005302-38 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Lateral Canthal Lines With ... | 2021-01-25 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2015-000609-38 | A Phase 2B Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects with Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to A... | 2018-01-29 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2015-002131-18 | A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2023-05-31 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2015-003631-34 | A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2021-01-26 | bad-data |
| Reported results | 2016-000756-98 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipolar... | 2018-01-18 | due-trials |
| Reported results | 2016-000757-13 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipolar... | 2017-07-19 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2016-004566-26 | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic S... | 2021-03-09 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2016-004754-15 | Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) | 2021-04-21 | bad-data |
| Reported results | 2017-000803-25 | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF CARIPRAZINE IN A DOSE-REDUCTION PARADIGM IN THE PREVENTION OF... | 2022-09-05 | due-trials |
| Reported results | 2017-000818-34 | A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF CARIPRAZINE IN A DOSE-REDUCTION PARADIGM IN THE PREVENTION OF... | 2021-02-11 | due-trials |
| Reported results Terminated | 2017-002136-16 | A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis | 2020-09-04 | due-trials |
| Reported results | 2017-002143-15 | A 46-week, Double-blind, Placebo-controlled, Phase 3 Study with a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis | 2020-10-30 | due-trials |
| Reported results | 2017-002144-33 | A 52-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis | 2020-11-05 | due-trials |
| Reported results | 2017-002177-20 | A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis | 2020-09-04 | due-trials |
| Ongoing | 2017-003770-14 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Eluxadoline in Pediatric Participants (Age 6 to 17 Years) with Irrit... | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2017-004399-68 | A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A (AGN 151607) Injections into the Epicardial Fat ... | 2023-03-06 | bad-data |
| Reported results Terminated | 2018-000060-29 | A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Monotherapy in Patients with Major Depressive Disorder | 2019-06-20 | due-trials |
| Listed as ongoing, but also has a completion date | 2018-000063-88 | A Randomized, Double-blind, Placebo- and Active- controlled, Multicenter Study of Rapastinel as Monotherapy in Major Depressive Disorder | 2019-06-20 | bad-data |
| Reported results Terminated | 2018-000064-28 | A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel in the Prevention of Relapse in Patients with Major Depressive Disorder | 2019-06-20 | due-trials |
| Listed as ongoing, but also has a completion date | 2018-001605-93 | A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants wi... | 2023-10-23 | bad-data |
| Ongoing | 2018-002574-52 | A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2018-002782-19 | A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRESSA... | 2021-09-30 | bad-data |
| Reported results | 2018-003164-31 | A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRESSA... | 2021-09-06 | due-trials |
| Ongoing | 2018-003597-26 | An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension | not-yet-due | |
| Other | 2018-004006-26 | A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17... | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2018-004337-32 | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ATOGEPANT FOR THE PREVENTION OF CHRONIC MIGRAINE (PROGR... | 2022-02-23 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2018-004346-42 | A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab i... | 2023-10-18 | bad-data |
| Reported results | 2018-004384-31 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines. | 2021-01-25 | due-trials |
| Reported results | 2018-004785-33 | A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (according to standard clinical prac... | 2022-07-04 | due-trials |
| Completed, but no date, and reported results Terminated | 2019-000406-30 | Open-label Extension Study of Relamorelin for the Treatment of Diabetic Gastroparesis | bad-data | |
| Listed as ongoing, but also has a completion date | 2019-001500-38 | A Phase 3, Multicenter, Randomized, Double-blind, Placebo controlled, Parallel-group, Safety and Efficacy Study of Linaclotide Administered Orally to Children, Ages 6 to 17 Years, With Functional Cons... | 2024-05-29 | bad-data |
| Listed as ongoing, but also has a completion date and reported results | 2019-001866-14 | An Open-label, Long-term Extension Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease (INTREPID OLE) Studio di estensione a lungo termine in aperto volto a esami... | 2023-09-19 | bad-data |
| Completed, but no date | 2019-001955-38 | A Phase 3, Open-label, Long-term Safety Study of Oral Linaclotide Administered to Pediatric Participants with Functional Constipation (FC) or Irritable Bowel Syndrome with Constipation (IBS-C) | bad-data | |
| Trial is outside EEC, and reported results | 2019-002126-75 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Sequential, Ascending, Multidose Study to Evaluate the Safety and Efficacy of Linaclotide in Pediatric Participants (Age 2 to 5 Years) with Fun... | bad-data | |
| Listed as ongoing, but also has a completion date and reported results | 2019-003448-58 | A Phase 3, Multicenter, Randomized, Double-blind, Placebo controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prophylaxis of Migraine in Parti... | 2022-08-04 | bad-data |
| Ongoing | 2020-002470-27 | A PHASE 3, MULTICENTER, OPEN-LABEL 104-WEEK EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ORAL ATOGEPANT FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH CHRONIC OR EPISODIC ... | not-yet-due | |
| Trial is outside EEC, and reported results | 2022-000415-32 | Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months With Suspected or Confirmed Bacterial Infection | bad-data |